These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 36745808)

  • 1. Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson's disease models.
    Nourse JB; Russell SN; Moniz NA; Peter K; Seyfarth LM; Scott M; Park HA; Caldwell KA; Caldwell GA
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2210712120. PubMed ID: 36745808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans.
    Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA
    PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
    Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
    Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans.
    Cao S; Gelwix CC; Caldwell KA; Caldwell GA
    J Neurosci; 2005 Apr; 25(15):3801-12. PubMed ID: 15829632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.
    Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK
    Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans.
    Masoudi N; Ibanez-Cruceyra P; Offenburger SL; Holmes A; Gartner A
    PLoS Genet; 2014 Dec; 10(12):e1004767. PubMed ID: 25474638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration.
    Morton KS; Hartman JH; Heffernan N; Ryde IT; Kenny-Ganzert IW; Meng L; Sherwood DR; Meyer JN
    BMC Biol; 2023 Nov; 21(1):252. PubMed ID: 37950228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
    Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
    PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
    Yan J; Yang Z; Zhao N; Li Z; Cao X
    BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evolutionarily Conserved Pathway Essential for Orsay Virus Infection of
    Jiang H; Chen K; Sandoval LE; Leung C; Wang D
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
    Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
    Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration.
    Nass R; Blakely RD
    Annu Rev Pharmacol Toxicol; 2003; 43():521-44. PubMed ID: 12415122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal prostaglandin E synthase-1 is a critical factor in dopaminergic neurodegeneration in Parkinson's disease.
    Ikeda-Matsuo Y; Miyata H; Mizoguchi T; Ohama E; Naito Y; Uematsu S; Akira S; Sasaki Y; Tanabe M
    Neurobiol Dis; 2019 Apr; 124():81-92. PubMed ID: 30423474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 protects dopaminergic neurons against degeneration in animal model of Parkinson's disease.
    Smit RD; Ghosh B; Campion TJ; Stingel R; Lavell E; Hooper R; Fan X; Soboloff J; Smith GM
    Brain Res; 2024 Feb; 1824():148691. PubMed ID: 38030102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.
    Benedetto A; Au C; Avila DS; Milatovic D; Aschner M
    PLoS Genet; 2010 Aug; 6(8):. PubMed ID: 20865164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
    Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
    CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
    Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
    Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaredoxin deficiency exacerbates neurodegeneration in C. elegans models of Parkinson's disease.
    Johnson WM; Yao C; Siedlak SL; Wang W; Zhu X; Caldwell GA; Wilson-Delfosse AL; Mieyal JJ; Chen SG
    Hum Mol Genet; 2015 Mar; 24(5):1322-35. PubMed ID: 25355420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.